| Application no. and date | 16728566.7 (espacenet) (Federated) (European Patent Register), 20160602 | | Patent/reg. no. and date | DK/EP 3303334, 20210602 | | Publication date | 20180411 | | Priority no. and date | US 201562170547 P, 20150603, US 201562271689 P, 20151228 | | EP pub. no. and date |
EP 3303334 20180411 | | Effective date | | | Applicant/owner | Principia Biopharma Inc., 220 East Grand Avenue
South San Francisco, CA 94080, US | | Applicant ref. no. | V344693DK00 | | Inventor | GOLDSTEIN, David, 122 Danbury Lane
Redwood City, California 94061, US,
OWENS, Timothy D., 800 Newport Cir
Redwood City, California 94061, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/437 (2006.01) , A61K 31/52 (2006.01) , A61P 35/00 (2006.01) , A61P 37/00 (2006.01) , C07D 471/04 (2006.01) , C07D 473/34 (2006.01) | | Title | Tyrosinkinasehæmmere | | Int. application no. | US2016035588 | | Int. publication no. | WO2016196840 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
